服务热线
Anti-PDCD1/CD279/PD1 mAbs [Pembrolizumab Biosimilar] (MABL-5078)
Anti-SARS-CoV-2 Spike RBD mAbs [Pemivibart Biosimilar] (MABL-5079)
Anti-CSF2 mAbs [Otilimab Biosimilar] (MABL-5047)
Anti-CD37 mAbs [Otlertuzumab Biosimilar] (MABL-5048)
Anti-IL4R/CD124 mAbs [Oturkibart Biosimilar] (MABL-5049)
Anti-TNFSF4/CD134/CD252/OX40L mAbs [Oxelumab Biosimilar] (MABL-5050)
Anti-RTN4/Nogo mAbs [Ozanezumab Biosimilar] (MABL-5051)
Anti-TNFRSF10B/CD262/DR5/TRAILR2 mAbs [Ozekibart Biosimilar] (MABL-5052)
Anti-TNF/TNFA;ALB mAbs [Ozoralizumab Biosimilar] (MABL-5053)
Anti-IGHE mAbs [Ozureprubart Biosimilar] (MABL-5054)
Anti-ROR2 mAbs [Ozuriftamab Biosimilar] (MABL-5055)
Anti-TFRC/CD71 mAbs [Pabinafusp Biosimilar] (MABL-5056)
Anti-TNFRSF17/CD269/BCMA/TNFRSF13A;CD3E mAbs [Pacanalotamab Biosimilar] (MABL-5057)
Anti-IL6 mAbs [Pacibekitug Biosimilar] (MABL-5058)
Anti-PDL1/CD274 mAbs [Pacmilimab Biosimilar] (MABL-5059)
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
陕ICP备2021006339号